BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Roderburg C, Bubenzer J, Spannbauer M, O ND, Mahnken A, Ludde T, Trautwein C, Tischendorf JJ. Long-term survival of a HCC-patient with severe liver dysfunction treated with sorafenib. World J Hepatol 2010; 2(6): 239-242 [PMID: 21161003 DOI: 10.4254/wjh.v2.i6.239]
URL: https://www.wjgnet.com/1948-5182/full/v2/i6/239.htm
Number Citing Articles
1
Xiangxuan Zhao, Changhai Tian, William M Puszyk, Olorunseun O Ogunwobi, Mengde Cao, Ton Wang, Roniel Cabrera, David R Nelson, Chen Liu. OPA1 downregulation is involved in sorafenib-induced apoptosis in hepatocellular carcinomaLaboratory Investigation 2013; 93(1): 8 doi: 10.1038/labinvest.2012.144
2
Jonathan H. Sherman, Jared Kirzner, Alan Siu, Samson Amos, Isa M. Hussaini. Sorafenib tosylate as a radiosensitizer in malignant astrocytomaJournal of Clinical Neuroscience 2014; 21(1): 131 doi: 10.1016/j.jocn.2013.04.010